Prescribing patterns and healthcare costs of gout

Yi Yun Lee; Li Na Kuo; Jin Hua Chen; Yi Chun Lin; Lung Fang Chen; Yu Ko

doi:10.1080/03007995.2018.1552577

Prescribing patterns and healthcare costs of gout

Yi Yun Lee, Li Na Kuo, Jin Hua Chen, Yi Chun Lin, Lung Fang Chen, Yu Ko

Research output: Contribution to journal › Article › peer-review

3 Citations (Scopus)

Abstract

Objective/methods: The Longitudinal Health Insurance Database (LHID) 2010 was used to identify gout cases and their number of gout flares. Results: Out of 21,376 gout patients, a total of 3561 (16.7%) had frequent gout flares (≥3 gout flares/year). Average all-cause healthcare utilization (35.9 visits vs. 30.7 visits; p <.001) and gout-related utilization (22.7 visits vs. 15.6 visits; p <.001) were higher in frequent gout flare patients than in those with infrequent gout flares. The median gout-related cost (USD $369 vs. $285; p <.001), but not all-cause costs (p =.25), were higher in frequent gout flare patients compared to the infrequent group. Over 55.8% of the flares were treated with colchicine + NSAIDs. Conclusions: In conclusion, patients with frequent gout flares had higher healthcare utilization and gout-related healthcare costs. Colchicine + NSAIDs are commonly used therapy for gout flare.

Original language	English
Pages (from-to)	1051-1058
Number of pages	8
Journal	Current Medical Research and Opinion
Volume	35
Issue number	6
DOIs	https://doi.org/10.1080/03007995.2018.1552577
Publication status	Published - Jun 3 2019

Keywords

costs
Gout
prescribing patterns
Taiwan

ASJC Scopus subject areas

General Medicine

Access to Document

10.1080/03007995.2018.1552577

Cite this

@article{7634edad8b7e491aa731ef693f83234a,

title = "Prescribing patterns and healthcare costs of gout",

abstract = "Objective/methods: The Longitudinal Health Insurance Database (LHID) 2010 was used to identify gout cases and their number of gout flares. Results: Out of 21,376 gout patients, a total of 3561 (16.7%) had frequent gout flares (≥3 gout flares/year). Average all-cause healthcare utilization (35.9 visits vs. 30.7 visits; p <.001) and gout-related utilization (22.7 visits vs. 15.6 visits; p <.001) were higher in frequent gout flare patients than in those with infrequent gout flares. The median gout-related cost (USD $369 vs. $285; p <.001), but not all-cause costs (p =.25), were higher in frequent gout flare patients compared to the infrequent group. Over 55.8% of the flares were treated with colchicine + NSAIDs. Conclusions: In conclusion, patients with frequent gout flares had higher healthcare utilization and gout-related healthcare costs. Colchicine + NSAIDs are commonly used therapy for gout flare.",

keywords = "costs, Gout, prescribing patterns, Taiwan",

author = "Lee, {Yi Yun} and Kuo, {Li Na} and Chen, {Jin Hua} and Lin, {Yi Chun} and Chen, {Lung Fang} and Yu Ko",

note = "Funding Information: This study was funded by the Ministry of Science and Technology, R.O.C (MOST 105-2314-B-038-005) and the Wan Fang Hospital, Taipei, Taiwan (104TMU-WFH-09). Publisher Copyright: {\textcopyright} 2019, {\textcopyright} 2019 Informa UK Limited, trading as Taylor & Francis Group.",

year = "2019",

month = jun,

day = "3",

doi = "10.1080/03007995.2018.1552577",

language = "English",

volume = "35",

pages = "1051--1058",

journal = "Current Medical Research and Opinion",

issn = "0300-7995",

publisher = "Taylor and Francis Ltd.",

number = "6",

}

TY - JOUR

T1 - Prescribing patterns and healthcare costs of gout

AU - Lee, Yi Yun

AU - Kuo, Li Na

AU - Chen, Jin Hua

AU - Lin, Yi Chun

AU - Chen, Lung Fang

AU - Ko, Yu

N1 - Funding Information: This study was funded by the Ministry of Science and Technology, R.O.C (MOST 105-2314-B-038-005) and the Wan Fang Hospital, Taipei, Taiwan (104TMU-WFH-09). Publisher Copyright: © 2019, © 2019 Informa UK Limited, trading as Taylor & Francis Group.

PY - 2019/6/3

Y1 - 2019/6/3

N2 - Objective/methods: The Longitudinal Health Insurance Database (LHID) 2010 was used to identify gout cases and their number of gout flares. Results: Out of 21,376 gout patients, a total of 3561 (16.7%) had frequent gout flares (≥3 gout flares/year). Average all-cause healthcare utilization (35.9 visits vs. 30.7 visits; p <.001) and gout-related utilization (22.7 visits vs. 15.6 visits; p <.001) were higher in frequent gout flare patients than in those with infrequent gout flares. The median gout-related cost (USD $369 vs. $285; p <.001), but not all-cause costs (p =.25), were higher in frequent gout flare patients compared to the infrequent group. Over 55.8% of the flares were treated with colchicine + NSAIDs. Conclusions: In conclusion, patients with frequent gout flares had higher healthcare utilization and gout-related healthcare costs. Colchicine + NSAIDs are commonly used therapy for gout flare.

AB - Objective/methods: The Longitudinal Health Insurance Database (LHID) 2010 was used to identify gout cases and their number of gout flares. Results: Out of 21,376 gout patients, a total of 3561 (16.7%) had frequent gout flares (≥3 gout flares/year). Average all-cause healthcare utilization (35.9 visits vs. 30.7 visits; p <.001) and gout-related utilization (22.7 visits vs. 15.6 visits; p <.001) were higher in frequent gout flare patients than in those with infrequent gout flares. The median gout-related cost (USD $369 vs. $285; p <.001), but not all-cause costs (p =.25), were higher in frequent gout flare patients compared to the infrequent group. Over 55.8% of the flares were treated with colchicine + NSAIDs. Conclusions: In conclusion, patients with frequent gout flares had higher healthcare utilization and gout-related healthcare costs. Colchicine + NSAIDs are commonly used therapy for gout flare.

KW - costs

KW - Gout

KW - prescribing patterns

KW - Taiwan

UR - http://www.scopus.com/inward/record.url?scp=85059699441&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059699441&partnerID=8YFLogxK

U2 - 10.1080/03007995.2018.1552577

DO - 10.1080/03007995.2018.1552577

M3 - Article

AN - SCOPUS:85059699441

SN - 0300-7995

VL - 35

SP - 1051

EP - 1058

JO - Current Medical Research and Opinion

JF - Current Medical Research and Opinion

IS - 6

ER -

Prescribing patterns and healthcare costs of gout

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this